index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

87

 

NOTICES

151

 

 

MOTS CLES

Anxiété Abus d'antibiotiques Anti-HCV Direct Acting Antivirals DAA Adverse side effects Albinism Biomarkers Graft-versus-host disease Bacterial Arthritis Etanercept Alcohol Spondyloarthritis Cardiomyopathy Immunotherapy Apremilast Dermatology Autoimmunity Meta-Analysis Pharmacoepidemiology Quality of life Primary adrenal insufficiency Burden Cancer Anxiety Biologic Axial spondyloarthritis Management Anticancer drugs Apre-milast Biological therapy Pharmacovigilance COVID-19 Auto-Diagnostic Treatment Sacroiliitis Endocrine toxicity Arrhythmia Méta-Analyse Vigibase® Psoriasis Antibiotic resistance Immune checkpoint inhibitors Prostate cancer Antibiotics Biological Therapy Sipuleucel-T Ustekinumab Antimicrobiens Epidemiology Ankylosing Stability ASDAS Ankylosing spondylitis Addiction Biologic drug Pregnancy Anti-TNF Autoimmune diseases Infliximab Auto-immune hepatitis Biologics Aging Angiotensin receptor blockers ArtThese BTK protein Cardio-oncology Amyloidosis Cardiotoxicity Access to care Antimicrobial Stewardship Beta-lactam antibiotics Antimicrobials Accelerometer Azathioprine Biosimilar Pharmaceuticals Biomédicaments Glucocorticoids CTLA-4 Intensive care Acute Myeloid Leukaemia AML Adolescent Adalimumab Antibiotic misuse Alitretinoin Placebo Immune-related adverse events Psoriatic arthritis Angiotensin-converting enzyme inhibitors CSK tyrosine-protein kinase Drug reaction Drug survival Biologic therapy Ethics Bacterial rhinosinusitis Pharmaco-Épidémiologie Calcium channel blockers Antimicrobial resistance Atrial fibrillation Atopic dermatitis Anti-Bacterial Agents

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS